Study: A Novel Medication for the Most Difficult-to-Treat Hemophilia Patients
March 29, 2023
Study results are promising for an investigational drug to prevent bleeding in patients with a severe clotting disorder.
Content related to CHLA Experts to Present at 2024 American Society of Hematology Meeting
A Closer Look: Why Is Research Essential at a Children’s Hospital?
July 20, 2023
The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.
Will N-Acetylcysteine Be the Next Therapy to Prevent Cisplatin-Induced Hearing Loss?
July 24, 2023
A CHLA clinical trial finds that N-acetylcysteine may be a promising next-generation therapy to reduce the risk of cisplatin-induced hearing loss.
Channeling Challenge Into Community: Hunter’s Story
September 10, 2024
Hunter never let his acute lymphoblastic leukemia diagnosis define him—but today, he proudly wears the title “survivor” in support of cancer research.
Can a Novel Approach Lead to Less-Toxic Treatments for Leukemia?
October 27, 2023
A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.
Children’s Hospital Los Angeles Names James F. Amatruda, MD, PhD, as Director of the Cancer and Blood Disease Institute
August 13, 2024
LOS ANGELES (August 13, 2024) – Children’s Hospital Los Angeles has named James F. Amatruda, MD, PhD, a highly respected medical leader, clinician, and researcher with global recognitions, as Director
Why Is it Important to Choose a Pediatric Research Hospital With Access to Clinical Trials?
October 10, 2023
Every cancer treatment that now exists for children was tested in a clinical trial. Clinical research and clinical trials are the only way to develop new and better therapies for children who have
Children’s Oncology Group Collaborators Publish Latest Findings on Post-Relapse Survival for Acute Lymphoblastic Leukemia
October 2, 2024
A statistical analysis of the largest study cohort to date sheds light on improvements—and gaps—in post-relapse treatment for Acute Lymphoblastic Leukemia.
Early Career Researchers Offer Glimpses Into Their Research During Data Blitz at The Saban Research Institute Science Day 2024
July 19, 2024
Poster session finalists were voted on by a scientific committee and presented key takeaways from their research during Science Day 2024.